Reduced expression of p53 and cyclin A in intraductal mucin- hypersecreting neoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma

American Journal of Gastroenterology

Volumn 94, Issue 8, 1999, Pages 2263-2267

  Mukawa, Kenji ^a   Kawa, Shigeyuki ^a   Aoki, Yuji ^a   Zhai, Yali ^a   Nikaido, Toshio ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; MUCIN; PROTEIN P53;

ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CARCINOGENESIS; CLINICAL ARTICLE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; TOPOGRAPHY;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; CYCLIN A; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033179719     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01303.x     Document Type: Article

References (15)

1. Rickaer F., Cremer M., Deviere J., et al. Intraductal mucin-hypersecreting neoplasms of the pancreas A clinicopathologic study of eight patients. Gastroenterology. 101:1991;512-519.
2. Tenner S., Carr-Locke D.L., Banks P.A., et al. Intraductal mucin-hypersecreting neoplasm "mucinous ductal ectasia" Endoscopic recognition and management. Am J Gastroenterol. 91:1996;2548-2554.
3. Scarpa A., Capelli P., Mukai K., et al. Pancreatic adenocarcinomas frequency show p53 gene mutations. Am J Pathol. 142:1993;1534-1543.
4. Sessa F., Solcia E., Capella C., et al. Intraductal papillary-mucinous tumors represent a distinct group of pancreatic neoplasms An investigation of tumour cell differentiation and K-ras, p53 and c-erb B-2 abnormalities in 26 patients. Virchow Archiv. 425:1994;357-367.
5. Gansauge S., Gansausauge F., Ramadani M., et al. Overexpression of Cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res. 57:1997;1634-1637.
6. Nikaido T., Li S.F., Shiozawa T., et al. Coabnormal expression of cyclin D1 and p53 protein in human endometrial carcinomas. Cancer. 78:1996;1248-1253.
7. Shiozawa T, Lu Xin, Nikaido T, et al. Immunohistochemical detection of cyclin A with reference to p53 expression in endometrial endometrioid carcinomas. Int J Gynecol Pathol 1997;16:348-53.
8. Yamamoto M., Yoshida M., Ono K., et al. Effect of tumor suppressers on cell cycle regulatory genes RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression. Ext Cell Res. 210:1994;94-101.
9. MacCormick D., Gold R., Downs J., et al. Detection of the Ki-67 antigen in fixed and wax-embedded sections with monoclonal antibody MIB1. Histopathology. 22:1993;355-360.
10. Navone N.H., Troncoso P., Pister L.L., et al. p53 accumulation and gene mutation in the progression of humanprostate carcinoma. J Natl Cancer Inst. 85:1993;1657-1669.
11. Linder S., Parrado C., Falkmer U.G., et al. Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material. Br J Cancer. 76:1997;54-59.
12. Furukawa T., Takahashi T., Kobari M., et al. The mucus-hypersecreting tumor of the pancreas Development and extension visualized by three-dimensional computerized mapping . Cancer. 70:1992;1505-1513.
13. Finlay C.A., Hids P.W., Levine A.J. The p53 proto-oncogene can act as a suppresser of transformation. Cell. 57:1989;1083-1093.
14. Yin Y., Tainsky M.A., Bischoff F.Z., et al. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 70:1992;937-948.
15. Bodner S.M., Minna J.D., Jensen S.M., et al. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene. 7:1992;743-749.